Prestige Consumer Healthcare (NYSE:PBH) Shares Gap Up Following Strong Earnings

Prestige Consumer Healthcare Inc. (NYSE:PBH) shares gapped up before the market opened on Thursday following a better than expected earnings announcement. The stock had previously closed at $76.10, but opened at $80.90. Prestige Consumer Healthcare shares last traded at $80.96, with a volume of 14,133 shares.

The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. DA Davidson reaffirmed a “buy” rating and set a $95.00 price target on shares of Prestige Consumer Healthcare in a research report on Monday, November 11th. StockNews.com raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. Sidoti cut Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price target for the company. in a research note on Monday, December 9th. Finally, Raymond James upgraded Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Prestige Consumer Healthcare has an average rating of “Moderate Buy” and an average price target of $85.25.

Insider Buying and Selling

In other Prestige Consumer Healthcare news, insider William P’pool sold 8,987 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $81.85, for a total transaction of $735,585.95. Following the completion of the transaction, the insider now directly owns 20,058 shares of the company’s stock, valued at approximately $1,641,747.30. This trade represents a 30.94 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Ronald M. Lombardi sold 10,875 shares of Prestige Consumer Healthcare stock in a transaction that occurred on Tuesday, November 19th. The shares were sold at an average price of $82.60, for a total transaction of $898,275.00. Following the sale, the chief executive officer now owns 320,952 shares of the company’s stock, valued at approximately $26,510,635.20. The trade was a 3.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 38,810 shares of company stock worth $3,187,300 in the last 90 days. Insiders own 1.60% of the company’s stock.

Institutional Investors Weigh In On Prestige Consumer Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Kestra Investment Management LLC purchased a new stake in shares of Prestige Consumer Healthcare in the fourth quarter worth about $27,000. Northwestern Mutual Wealth Management Co. lifted its holdings in Prestige Consumer Healthcare by 562.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company’s stock valued at $35,000 after acquiring an additional 433 shares during the period. nVerses Capital LLC lifted its holdings in Prestige Consumer Healthcare by 200.0% in the third quarter. nVerses Capital LLC now owns 600 shares of the company’s stock valued at $43,000 after acquiring an additional 400 shares during the period. Huntington National Bank boosted its position in Prestige Consumer Healthcare by 39.9% in the 3rd quarter. Huntington National Bank now owns 635 shares of the company’s stock worth $46,000 after purchasing an additional 181 shares in the last quarter. Finally, International Assets Investment Management LLC grew its stake in shares of Prestige Consumer Healthcare by 7,112.5% during the 3rd quarter. International Assets Investment Management LLC now owns 1,154 shares of the company’s stock worth $83,000 after purchasing an additional 1,138 shares during the period. 99.95% of the stock is owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Stock Performance

The company has a current ratio of 3.56, a quick ratio of 2.10 and a debt-to-equity ratio of 0.61. The firm’s fifty day moving average price is $79.13 and its two-hundred day moving average price is $75.26. The stock has a market capitalization of $4.31 billion, a PE ratio of 21.22, a price-to-earnings-growth ratio of 2.15 and a beta of 0.50.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.